does bpc 157 require a prescription FDA advisory committee votes to add popular peptide BPC-157 to drug compounding list BPC-157 Peptide | BPC-157 Synthetic

Cartilage presents unique challenges because it lacks direct blood supply and has limited self-repair capacity

IM injections allow for slow absorption into the blood, providing a longer-lasting effect

Each component is not FDA-approved and was removed from 503B bulk-compounding eligibility in 2024

Melanocortin and Metabolic Peptides: A Different Research Category Entirely Peptides like Melanotan II (melanocortin receptor agonist) and GLP-1 receptor agonists like Semaglutide and Tirzepatide act through completely different receptor systems melanocortin receptors and GLP-1 receptors respectively with no mechanistic overlap with BPC-157

There is no completed human efficacy trial, which is why all dosing here is research-use-only